Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

RSS icon

Playtime reduces heart failure risk

Thanks to a Swedish study, we can add one more benefit to the list when talking about increasing down-time activity levels: reduced heart failure risks.

Thumbnail

Heart failure patients with afib get little benefit from beta-blockers

Beta-blockers appeared to offer no or little clinical benefit to patients with heart failure and atrial fibrillation in a study presented at the European Society of Cardiology’s annual meeting and concurrently published online Sept. 2 in The Lancet.

IN-TIME trial confirms a 50 percent reduction in mortality in heart failure patients while EuroEco and ECOST demonstrate economic savings

Experts discussed the benefits of Home Monitoring technology from the perspective of patients, hospitals and payers for the first time at a press conference held by BIOTRONIK at the European Society of Cardiology's annual congress, ESC Congress 2014.

Thumbnail

Combo heart failure drug promises to improve survival

A novel drug that combines an ARB with a neprilysin inhibitor proved superior to the ACE inhibitor enalapril, even when the latter was prescribed at its target dose, for reducing the risk of death and hospitalization for heart failure in patients with reduced ejection fraction.

Thumbnail

Medtronic set to launch CRT-pacemaker

The FDA approved a cardiac resynchronization therapy-pacemaker (CRT-P) for patients with heart failure or atrioventricular block.

1 in 3 heart failure patients will revisit ED frequently

Almost one-third of patients who visit the emergency department for acute heart failure will return two or more times within a year, results published online Aug. 19 showed. Could readmissions penalties exacerbate the problem?

Thumbnail

Telemonitoring gets to heart failure patients IN-TIME

The IN-TIME study showed an improvement in clinical outcomes in patients with heart failure who were telemonitored, according to results published online Aug. 16 in The Lancet.

HeartWare International announces appointment of Katrin Leadley, M.D., as chief medical officer

Framingham, Mass., August 4, 2014 – HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the appointment of Katrin Leadley, M.D., as Chief Medical Officer of HeartWare, effective September 1, 2014. 

Displaying 993 - 1000 of 1270

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.